21st Austria weekly - Valneva EVN 25/02/2022 [pic1]Valneva: Valneva SE an Austrian/French specialty vaccine company today announced that the Committee for Medicinal Products Human Use CHMP of European Medicines Agency EMA has provided initial assessment Valneva’s inactivated adjuvanted COVID-19
21st Austria weekly - Valneva EVN 25/02/2022 [pic1]Valneva: Valneva SE an Austrian/French specialty vaccine company today announced that the Committee for Medicinal Products Human Use CHMP of European Medicines Agency EMA has provided initial assessment Valneva’s inactivated adjuvanted COVID-19